These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Change in the cells that express connective tissue growth factor in acute Coxsackievirus-induced myocardial fibrosis in mouse. Yun SH, Shin JO, Lim BK, Kim KL, Gil CO, Kim DK, Jeon ES. Virus Res; 2007 Jun; 126(1-2):62-8. PubMed ID: 17350707 [Abstract] [Full Text] [Related]
6. Regulatory T cells protect mice against coxsackievirus-induced myocarditis through the transforming growth factor beta-coxsackie-adenovirus receptor pathway. Shi Y, Fukuoka M, Li G, Liu Y, Chen M, Konviser M, Chen X, Opavsky MA, Liu PP. Circulation; 2010 Jun 22; 121(24):2624-34. PubMed ID: 20530002 [Abstract] [Full Text] [Related]
7. Coxsackievirus-induced myocarditis is dependent on distinct immunopathogenic responses in different strains of mice. Huber SA. Lab Invest; 1997 May 22; 76(5):691-701. PubMed ID: 9166288 [Abstract] [Full Text] [Related]
8. Trace element distribution in heart tissue sections studied by nuclear microscopy is changed in Coxsackie virus B3 myocarditis in methyl mercury-exposed mice. Ilbäck NG, Lindh U, Wesslén L, Fohlman J, Friman G. Biol Trace Elem Res; 2000 May 22; 78(1-3):131-47. PubMed ID: 11314973 [Abstract] [Full Text] [Related]
9. [Experimental comparison of two coxsackievirus B3 variants in murine myocardial cells]. Cui X, Gomez R, Sun G, Ma L, Xu Z. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Sep 22; 11(3):274-6. PubMed ID: 15617347 [Abstract] [Full Text] [Related]
10. Atorvastatin attenuates Coxsackie virus B3m-induced viral myocarditis in mice. Guan J, Sun X, Liang Y, Dong W, Zhang L, Zhu J, Wang G. J Cardiovasc Pharmacol; 2010 Nov 22; 56(5):540-7. PubMed ID: 20729751 [Abstract] [Full Text] [Related]
11. Glutathione depletion and cardiomyocyte apoptosis in viral myocarditis. Kytö V, Lapatto R, Lakkisto P, Saraste A, Voipio-Pulkki LM, Vuorinen T, Pulkki K. Eur J Clin Invest; 2004 Mar 22; 34(3):167-75. PubMed ID: 15025674 [Abstract] [Full Text] [Related]
12. Effects of levosimendan in experimental acute coxsackievirus myocarditis. Latva-Hirvelä J, Kytö V, Saraste A, Vuorinen T, Levijoki J, Saukko P. Eur J Clin Invest; 2009 Oct 22; 39(10):876-82. PubMed ID: 19772522 [Abstract] [Full Text] [Related]
13. Coxsackie virus B3 perimyocarditis in BALB/c mice: experimental model of chronic perimyocarditis in the right ventricle. Matsumori A, Kawai C. J Pathol; 1980 Jun 22; 131(2):97-106. PubMed ID: 6253611 [Abstract] [Full Text] [Related]
14. Pathogenesis of coxsackievirus B3-induced myocarditis: role of macrophage migration inhibitory factor. Yu XH, Li SJ, Chen RZ, Yang YZ, Zhang P. Chin Med J (Engl); 2012 Jan 22; 125(1):50-5. PubMed ID: 22340465 [Abstract] [Full Text] [Related]
16. The viral genetic background determines the outcome of coxsackievirus B3 infection in outbred NMRI mice. Schmidtke M, Merkle I, Klingel K, Hammerschmidt E, Zautner AE, Wutzler P. J Med Virol; 2007 Sep 22; 79(9):1334-42. PubMed ID: 17607777 [Abstract] [Full Text] [Related]
17. Osteopontin: a fibrosis-related marker molecule in cardiac remodeling of enterovirus myocarditis in the susceptible host. Szalay G, Sauter M, Haberland M, Zuegel U, Steinmeyer A, Kandolf R, Klingel K. Circ Res; 2009 Apr 10; 104(7):851-9. PubMed ID: 19246678 [Abstract] [Full Text] [Related]
18. Evidence of perforin-mediated cardiac myocyte injury in acute murine myocarditis caused by Coxsackie virus B3. Seko Y, Shinkai Y, Kawasaki A, Yagita H, Okumura K, Yazaki Y. J Pathol; 1993 May 10; 170(1):53-8. PubMed ID: 8392106 [Abstract] [Full Text] [Related]